Literature DB >> 17631332

Overactive bladder in children. Part 2: Management.

Israel Franco1.   

Abstract

PURPOSE: The management of pediatric overactive bladder syndrome has relied primarily on anticholinergics and a bowel regimen. In many cases the results have been ineffective and they have frustrated many parents, patients and practitioners. We explored other treatment modalities that may be more effective than the regimens that we currently use. A thorough understanding of the causes of overactive bladder syndrome are essential to help us find the appropriate treatment for individuals.
MATERIALS AND METHODS: We looked at numerous treatment modalities that are being used for overactive bladder syndrome and matched them to a specific cause of overactive bladder syndrome that would be best suited to treat the problem. The treatment of constipation as a mainstay for pediatric overactive bladder syndrome was explored as well as its different options. New treatment modalities involving electrical stimulation were explored as well as botulinum A toxin injections.
RESULTS: The effectiveness of each treatment was assessed, thereby providing the reader with a foundation for choosing the appropriate treatment.
CONCLUSIONS: The treatment of pediatric overactive bladder syndrome is not as simple as placing children on anticholinergics and, if there is no response, simply saying that they will outgrow it. The causes of overactive bladder syndrome are multifactorial and a better understanding of the pathophysiology will allow us to target treatments appropriately for individuals.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17631332     DOI: 10.1016/j.juro.2007.05.076

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  Self-report of difficult defecation is associated with overactive bladder symptoms.

Authors:  Anne Cameron; Dee E Fenner; John O L DeLancey; Daniel M Morgan
Journal:  Neurourol Urodyn       Date:  2010-09       Impact factor: 2.696

2.  Trends in Pharmacotherapy for Bladder Dysfunction Among Children in the United States, 2000 to 2013.

Authors:  Alan C Kinlaw; Michele Jonsson Funk; Michael J Steiner; Mitchell M Conover; Virginia Pate; Jennifer M Wu
Journal:  Clin Pediatr (Phila)       Date:  2016-07-19       Impact factor: 1.168

3.  The Impact of Gene Polymorphisms on the Success of Anticholinergic Treatment in Children with Overactive Bladder.

Authors:  Serhat Gurocak; Ece Konac; Iyimser Ure; Cem Senol; Ilke Hacer Onen; Sinan Sozen; Adnan Menevse
Journal:  Dis Markers       Date:  2015-06-24       Impact factor: 3.434

4.  Editorial: Urinary Incontinence in Children: Controversies Concerning the Bladder Outlet.

Authors:  Caroline Kuijper; Rafal Chrzan
Journal:  Front Pediatr       Date:  2018-08-08       Impact factor: 3.418

5.  Long-term follow-up after botulinum toxin A (BTX-A) injection into the detrusor for treatment of neurogenic detrusor hyperactivity in children.

Authors:  Mazen Zeino; Tanja Becker; Mark Koen; Christoph Berger; Marcus Riccabona
Journal:  Cent European J Urol       Date:  2012-09-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.